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Abstract
Background We aim to provide evidence that despite not
administering epinephrine, (1) the amount of hemorrhaging
during surgery will not change, (2) surgery time will not
increase and may even be shorter, and (3) there would be
fewer cardiovascular-related consequences.
Methods One hundred thirteen patients were enrolled and
randomized into the control (n = 74) and intervention
groups (n = 39). During the primary open or closed rhi-
noplasty operation, anesthesia was managed by continual
infusion of remifentanil (14–20 lg/h) and propofol
(4–6 mg/kg/h) with an infusion pump, in addition to
N2O–O2 (50%). Atracurium was repeated (5 mg every
20 min). Patients in the control group received an epi-
nephrine (1/100,000) injection to the nose, and patients in
the intervention group did not. All patients received
dexamethasone (8 mg IV) and metoclopramide (10 mg IV).
Attheendoftheoperationandbeforeextubation,themuscle
relaxants were reversed with prostigmine (0.35 mg/kg) and
atropine (0.175 mg/kg).
Results We found (1) no statistically signiﬁcant associa-
tion between epinephrine injection and hemorrhage during
or after surgery (P = 0.949), (2) a statistically signiﬁcant
association between epinephrine injection and complica-
tions, and (3) the group that did not receive the injection
had fewer complications (P = 0.01). With respect to the
duration of surgery, we did not detect any statistically
signiﬁcant associations between the groups.
Conclusion Elimination of epinephrine during rhinoplasty
as an alternative procedure may lead to the same surgery
outcomesifnotabetterone.Studieswithalargersamplesize
are needed to further substantiate these ﬁndings.
Keywords Epinephrine  Lidocaine  Rhinoplasty  Local
anesthetic
Introduction
With increasing demands for plastic surgery in recent
years, the number of rhinoplasties has also shown an
upward trend. The anatomy of the nose, with its vascular
structure and limited area for maneuvering, restricts the
surgeon’s access and visibility during a rhinoplasty.
Therefore, most surgeons have been using lidocaine/
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that we refer to, for similar terms, throughout the article)
with local anesthetics as a way to locally anesthetize and
prepare the region for operation. Indeed, this method has
become a standard procedure and current practice for most
plastic surgeons [1].
Local anesthetics containing epinephrine are also rou-
tinely used in functional endoscopic sinus surgery (FESS)
mainly for hemostasis [2]. In a survey of 360 otorhinolar-
yngologists in the UK, the majority of the surgeons reported
using cocaine preoperatively because it provides a greater
operativeﬁeld. Nearly 70%ofthese surgeons reported using
cocaine and epinephrine together. They considered cocaine
to be safe with epinephrine more so than with lidocaine [3].
Of concern are cardiovascular side effects of epinephrine
[1, 4, 5]. Sigg et al. [5] compared the hemostatic effect of a
high concentration of ornipressin (5 IU/10 ml) lidocaine in
patients undergoing rhinosurgery. They reported that under
halothane/enﬂurane anesthesia, a patient’s blood pressure
andheartratedidnotriseandremained virtuallyconstant up
to 15 min following local inﬁltration of ornipressin into the
nasal tissues. However, patients who were anesthetized with
diazepam/fentanyl experienced an elevation in blood pres-
sure following inﬁltration of ornipressin (1-ornipressin/
epinephrine).Therefore, they recommended against the use
of a high concentration (2-high concentration of mipressin/
epinephrine) for patients with blood pressure dyscrasias.
Others have warned surgeons about the rise in plasma
epinephrine concentrations within minutes of epinephrine
injection [6]. Hasselt et al. [6] compared plasma catechol-
amine concentrations after administering vasoconstrictor
solutions by Moffett’s method or submucosal inﬁltration of
epinephrine (4.4 ml of 1:80,000) and lignocaine (2%) in 20
patients undergoing elective nasal surgery. They reported
that plasma epinephrine concentrations increased by 44.3
times to a peak of 9.9 nmol/l (1,813 pg/ml) within 1 min,
whereas in patients who received Moffett’s solution con-
taining epinephrine (1 ml of 1:1,000), the peak level of
epinephrine was 1.27 nmol/l (232 pg/ml) occurred 10 min
after instillation of the solution (P\0.01).
Cotton et al. [7] argue against the so-called ‘‘safe dose’’
of epinephrine (i.e., 1.0 kg
-1 during halothane anesthesia).
They reported that the outcomes of inﬁltration of ligno-
caine (21 ml of 0.5%) with epinephrine (1:200,000) to the
facial area of rhinoplasty patients, and injection of ligno-
caine (40 ml of 0.5%), bupivacaine (0.25%), and epi-
nephrine (1:200,000) to patients undergoing brachial
plexus block were different based on the site of adminis-
tration. There was a 566% increase in plasma epinephrine
concentration 2 min after cessation of injection in the
rhinoplasty group, while they observed only a 112%
increase in the plasma concentration of epinephrine 10 min
after completion of the block in the brachial plexus group.
As highlighted in the above-cited literature, there is a
debate among surgeons regarding the use of epinephrine
with local anesthetics as a way to locally anesthetize and
prepare the region for operation. This debate is partly due
to the paucity of research providing convincing evidence
for a safe dose of a lidocaine/epinephrine combination,
especially for patients with a history of myocardial
infarction or those who are sensitive to epinephrine or
preservatives that are contained in lidocaine/epinephrine
combination.
The overall goal of this study was to provide empirical
evidence that administration of lidocaine/epinephrine with
local anesthetics does not have to be considered an indis-
pensable procedure in rhinoplasty. Speciﬁcally, we aimed
to provide evidence that despite not administering lido-
caine/epinephrine, (1) the amount of hemorrhaging during
surgery will not change, (2) surgery time will not increase
and even may be shorter, and (3) there would be fewer
cardiovascular-related consequences. We hypothesized that
rhinoplasty patients who do not receive lidocaine/epi-
nephrine as a local anesthetic (case/intervention group)
compared to their lidocaine/epinephrine-receiving coun-
terparts (control group) will be less likely to (1) have extra
hemorrhaging during/after surgery, (2) have prolonged
surgery time, and (3) develop cardiovascular-related com-
plications, including arrhythmia, hypertension, tachycardia,
and post-surgery chest pain.
Methods
Design and Procedure
This was a randomized control pilot study conducted in
Punzdahe Khordad Hospital, a plastic surgery center afﬁl-
iated with Shahid Beheshti University of Medical Sciences.
Patients were recruited to the study by posting study ﬂyers
in the surgery center from May 2008 to May 2009. Inter-
ested patients who called in were screened by the study
coordinator. If eligible and still interested, an initial
appointment for the informed consent procedure, further
screening, and collection of baseline information and
measurements was scheduled. To be eligible for the study,
male and female patients had to meet all the following
inclusion criteria: (1) be 18 years old or older, (2) sched-
uled for a primary open or closed rhinoplasty operation, (3)
have no history of or current cardiovascular diseases and
disorders, (4) have normal values for all the preoperation
laboratory test results (PT, PTT, and INR), and (5) willing
to sign an informed consent form. Patients who were par-
ticipating in another study and/or could not meet the
aforementioned criteria were excluded from the study. The
rest of the study procedures were conducted in three stages.
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During a scheduled initial visit, the following procedures
were conducted to ﬁnd out if the subjects met all the study
requirements and if it was safe for them to be involved in
the study. To do so, the study coordinator once more
screened potential subjects for participation eligibility and
explained the research protocol and all its details to them.
Patients were given ample amount of time to review the
informed consent form and were given an opportunity to
ask questions of the coordinator and/or physicians who
were involved in the trial. Only after all of the patients’
questions and concerns were answered did they sign and
date a written informed consent form. Only patients who
met all the study eligibility requirements and signed he
informed consent form were entered into the study and
were scheduled for the baseline assessment. The principle
of the study protocol was approved by the ethics committee
of Shahid Beheshti University of Medical Sciences.
Second Stage: Baseline
During the baseline visit, all enrolled patients received a
physical examination, and preoperation tests and sub-
sequent information were recorded. They also ﬁlled out a
baseline patient information sheet, including their contact
information; number of physician-diagnosed diseases, spe-
ciﬁcally cardiovascular diseases; past operations; allergies;
and medication history, including number and types of any
over-the-counter or physician-prescribed medications.
Again, all patients with any indication of cardiovascular
diseases were removed from the study.
Third Stage: Randomization
In this stage participating patients were randomly assigned
(using pre-group-assigned sealed envelopes) to either the
intervention group (n = 39) or the control group/standard
care (n = 74) using computerized random number
allocation.
Measurements
The study outcome variables include hemorrhage recorded
as \50 cc, between 50 and 100 cc, and [100 cc; surgery
duration recorded in minutes; and post-surgery temporary
cardiovascular complications measured as any sign of
arrhythmia (yes, no) and hypertension. Hypertension was
measured as minimum vs. maximum blood pressure (BP),
where patients with systolic B160 and diastolic B80 were
grouped in the normal BP category and those with systolic
[160 and diastolic[80 were grouped in the abnormal BP
category. Other variables in the study include gender
(male, female), age (18 and older), weight (kg), and pulse
rate (PR) (beats/min).
Rhinoplasty Procedures
All the operations (primary open and closed rhinoplasties)
were performed using the standard technique/protocol
without any changes. The steps to perform open rhino-
plasty were carried out in the following order: Typically,
the operation began by giving general anesthesia. This was
followed by the injection of anesthetic solution (lidocaine/
epinephrine), and ﬁnally making a columellar incision. The
steps to perform closed rhinoplasty were ﬁrst administering
general anesthesia, followed by injection of anesthetic
solution (lidocaine/epinephrine), and ﬁnally making an
intercartilaginous incision.
Of note, however, is that for the patients in the inter-
vention group, the second step in both the open and the
closed rhinoplasty was eliminated (i.e., they did not receive
the standard dose of lidocaine/epinephrine injection during
the surgery), and we made the incision right after general
anesthesia. Patients in the standard care group did receive
the standard dose of adrenalin injection before starting
surgery.
As is known, septoplasty can prolong the duration of the
rhinoplasty operation. To eliminate the threat of procedure
bias, patients who needed a septoplasty were equally
divided between cases and control groups.
Intervention
At ﬁrst, all patients were premedicated with midazolam
(1 mg IV) and remifentanil (1–1.5 lg/kg). Then they were
anesthetized with nesdonal (5 mg/kg) and atracurium
(0.6 mg/kg) as muscle relaxants. After 2 min, patients were
intubated with an appropriate tracheal tube and the cutoff
tube was ﬁlled with air and its pressure became constant at
25 cmH2O.
Following the injection, the septal ﬂap was elevated and
the submucosal area was resected. The nasal tip operation
was performed by transcartilage incision. Finally, the dorsal
hump was ﬂattened by rasp and cartilage excision using
scissors and a blade, and osteotomy was also performed.
Anesthesia was managed by continual infusion of rem-
ifentanil (14–20 lg/h) and propofol (4–6 mg/kg/h) with an
infusion pump, in addition to N2O–O2 (50%). Atracurium
was repeated (5 mg every 20 min). Then epinephrine was
injected into the nose of patients in the standard care group
(control group), but patients in the intervention group did
not receive this injection. All patients received dexameth-
asone (8 mg IV) and metoclopramide (10 mg IV).
At the end of the operation and before extuba-
tion, muscle relaxants were reversed with prostigmine
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123(0.35 mg/kg) and atropine (0.175 mg/kg). Except for the
elimination of the lidocaine/epinephrine injection for the
intervention group, all procedures used during the opera-
tion were considered standard measures or techniques for
any rhinoplasty surgery. During and after the operation,
exact recordings of possible arrhythmias, blood pressure
ﬂuctuations, and pulse rate variations were registered in
both the intervention and the standard care group. More-
over, all patients were asked if they were suffering from
cardiac symptoms (i.e., chest pain) after the operation.
Recovery time after the operation, the amount of bleeding,
and patient satisfaction were also recorded.
Data Analysis
Univariate analysis using descriptive statistics (i.e., fre-
quency, percentage, mean and standard deviation) was
used to present distributions of the main variables in the
study. Independent sample t tests and v
2 tests of association
were used, when appropriate, to evaluate differences in the
main outcome variables (i.e., hemorrhage, surgery dura-
tion, post-surgery temporary cardiovascular complica-
tions) between the intervention and the standard care
group. A P value of less than 0.05 was considered statis-
tically signiﬁcant. Data were analyzed using the SPSS ver.
16.0 (SPSS Inc., Chicago, IL).
Results
The main purpose of this study was to demonstrate that
administration of epinephrine with local anesthetics does
not have to be considered an indispensable procedure in
rhinoplasty operations. One hundred thirteen patients were
enrolled in the study and randomized into the control/
standard care group (n = 74) and the intervention group
(n = 39). The majority of patients were female (87.6%).
Participants’ mean age and standard deviation was
25.4 ± 7.3 years. No statistically signiﬁcant associations
were detected between the intervention group and the
standard care group with respect to the baseline charac-
teristics (age, gender, weight, BP) (Table 1).
We hypothesized that patients without injection of epi-
nephrine (the intervention group) will have less hemor-
rhaging, fewer complications, and a shorter surgery time.
Results of the v
2 test of associations indicated no statisti-
cally signiﬁcant association between epinephrine injection
and hemorrhage during or after surgery (P = 0.949).
Although more complications were recorded for patients in
the standard care group who received epinephrine (i.e., one
patient with arrhythmia, one patient with HTN, and three
patients with both complications) than in patients in the
intervention group for whom no complications were
recorded, the association was not statistically signiﬁcant
(P = 0.161). With respect to the duration of surgery, using
a t test, the average surgery time for the intervention group
was recorded as (mean ± SD) 113.7 ± 22.6 min com-
pared with the standard care group whose operation time
was 149.8 ± 23.9 min; the difference between the two
groups was statistically signiﬁcant (P = 0.001) (Table 2).
Discussion
There has been an upward trend in the number of rhino-
plasties in recent years. Also, more surgeons are using
epinephrine during the surgery. This study evaluated
whether elimination of epinephrine during the operation
would make any difference in the amount of bleeding
during and after surgery, the length of the operation, and
cardiovascular-related complications, including arrhyth-
mia, hypertension, tachycardia, and post-surgery chest
pain. Our ﬁndings showed that elimination of epinephrine
in fact signiﬁcantly shortened the length of surgery from
Table 1 Overall characteristics of the sample (n = 113)
Variable Frequency (%)
Adrenalin injection 74 (65.5)
Sex
Male 14 (12.4)
Female 99 (87.6)
Epinephrine not injected 39 (34.5)
Hemorrhage
\50 cc 72 (63.7)
50–100 cc 31(27.4)
[100 cc 10 (8.8)
Complications
Arrhythmia 1 (0.9)
Hypertension 1 (0.9)
None 108 (95.6)
Both 3 (2.7)
Procedure
Rhino closed (primary) 83 (73.4)
Septo Rhino open (primary) 30 (26.6)
Mean ± SD
Age [25.5 ± 7.3]
Weight [59.9 ± 10.6]
BP min [53.5 ± 6.5]
BP max [76.1 ± 9.3]
Pulse rate [71.8 ± 5.4]
PCO2 [22.1 ± 2.06]
O2sat [97.7 ± .79]
Time [126.1 ± 28.7]
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123149 min (average length of surgery in the control group) to
113.7 min (average length of surgery in the intervention
group) (P = 0.001); reduced the number of expected
complications in the intervention group, even though this
association was not statistically signiﬁcant; and did not add
an additional risk of bleeding.
Our evidence raises the possibility that elimination of
epinephrine during rhinoplasty as an alternative procedure
may in fact lead to the same surgery outcome if not better.
Indeed, we observed fewer complications among a few
patients who did not receive epinephrine. This ﬁnding adds
to the existing concerns regarding the use of epinephrine to
locally numb the area of operation during rhinoplasty.
Previous studies have suggested that during rhinoplasty
injection of epinephrine was more likely to elevate the
patient’s blood pressure, thus raising the risk of cardio-
vascular-related side effects. Koeppe et al. [1] argued that
injection of even a very small dose of epinephrine as a
local anesthetic can increase plasma catecholamines. In
their study, overall cardiovascular-related side effects of
prilocaine and lidocaine were reported at 5.9% of rhino-
plasties and 8.1% of face-lifts, percentages that they
believed were quite high for such procedures. They
strongly suggested that surgeons should use ropivacaine
more often since it offers signiﬁcant advantages in both
efﬁcacy and prolonged duration of analgesia. According to
their ﬁndings, use of ropivacaine also reduces the risk for
adverse side effects due to less toxicity.
Demirtas et al. [4] studied the hemodynamic effects of
lidocaine/epinephrine in healthy patients who underwent
rhinoplasty procedures. They concluded that after the
injection of these medications, a mild to moderate and
short-lasting tachycardia was detected. There was also an
increase in the pulse rate during lateral osteotomies.
John et al. [8] reported that all patients showed a marked
increase in plasma epinephrine concentration within 4 min
of injecting epinephrine 1:80,000 and 2% lignocaine.
Therefore, they warn surgeons to be aware of this marked
but unpredictable systemic absorption of locally inﬁltrated
vasoconstrictors during any functional endoscopic sinus
surgeries.
In a preliminary study, Yang et al. [2] reported that
among FESS patients, epinephrine (1:200,000) contained
in 2% lidocaine or saline did cause temporary hypotension
and other hemodynamic changes that lasted approximately
4 min. Surgeons have also been cautioned about the pos-
sibilities of drug interactions with the lidocaine/epineph-
rine combination [9].
In the current study, there was less of a chance of car-
diac issues by not using epinephrine; there were two
complications in the control group: one patient with
hypertension and one with an arrhythmia. Even though this
was not found to be signiﬁcant, not using epinephrine did
not add any additional cardiac complications and did not
increase the amount of bleeding in the intervention group.
Nonetheless, elimination of epinephrine did signiﬁcantly
reduce the duration of surgery and we did observe a trend
toward fewer complications in the intervention group.
Conclusion
This study was a randomized control pilot study. Patients
were randomized to either the intervention group (only
Table 2 Association between epinephrine, sex, age, hemorrhage, and complications across the intervention and control groups
Variable Control group
with epinephrine
(N = 74)
F (%)
Intervention group
without epinephrine
(N = 39)
F (%)
v P
Sex 6.26 0.016
Male 5 (6.8) 9 (23.0)
Female 69 (93.2) 30 (77.0)
Hemorrhage 0.104 0.949
\50 cc 47 (63.5) 25 (64.1)
50–100 cc 20 (27.0) 11 (28.2)
[100 cc 7 (9.5) 3 (7.7)
Complications 9.92 0.019
Arrhythmia 1 (2.6) 0 (0.0)
Hypertension 1 (2.5) 0 (0.0)
None 74 (100.0) 34 (87.1)
Both 0 (0.0) 3 (7.7)
Age [N,M± SD, t (df)] [74, 25.7 ± 7.3, 0.581 (111)] [39, 24.9 ± 7.3, 0.583 (77)] 0.562
Duration [N,M± SD, t (df)] [74, 149.8 ± 22.6, 7.88 (111)] [39, 113.7 ± 23.9, 7.75 (74)] 0.001
586 Aesth Plast Surg (2011) 35:582–587
123lidocaine injection) or the control group (lidocaine with
epinephrine). We aimed to show that epinephrine can be
avoided in the local anesthetic solution used for rhinoplasty.
Our results indicate that elimination of epinephrine for a
few patients in the intervention group reduced the number
of anticipated cardiac-related complications. Furthermore,
elimination of epinephrine did not add any additional risk
of bleeding assessed intraoperatively by sponge count and
total aspirate. Our ﬁndings also showed that elimination of
epinephrine reduced the length of surgery in the interven-
tion group, which could be partly due to the 5–10 min
saved by not having to inject the lidocaine/epinephrine.
These ﬁndings raise the possibility that elimination of
epinephrine during the rhinoplasty could be an alternative
procedure that may in fact lead to the same surgery out-
come if not a better one. Studies with a larger sample size
can help further substantiate these ﬁndings.
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